Document Detail

Oral cryotherapy reduces mucositis and opioid use after myeloablative therapy--a randomized controlled trial.
MedLine Citation:
PMID:  17393189     Owner:  NLM     Status:  MEDLINE    
INTRODUCTION: Mucositis is a major complication in myeloablative therapy, which often necessitates advanced pharmacological pain treatment, including i.v. opioids. Attempts to prevent oral mucositis have included oral cryotherapy, which has been shown to reduce mucositis, but there is a lack of knowledge concerning the effect of oral cryotherapy on opioid use by reducing the mucositis for patients treated with myeloablative therapy before bone marrow transplantation (BMT). AIM: The aim of the present study was to evaluate if oral cryotherapy could delay or alleviate the development of mucositis and thereby reduce the number of days with i.v. opioids among patients who receive myeloablative therapy before BMT. MATERIALS AND METHODS: Eighty patients 18 years and older, scheduled for BMT, were included consecutively and randomised to oral cryotherapy or standard oral care. A stratified randomisation was used with regard to type of transplantation. Intensity of pain, severity of mucositis and use of opioids were recorded using pain visual analogue scale (VAS) scores, mucositis index scores and medical and nursing charts. RESULTS: This study showed that patients receiving oral cryotherapy had less pronounced mucositis and significantly fewer days with i.v. opioids than the control group. In the autologous setting, cryotherapy patients also needed significantly lower total dose of opioids. CONCLUSION: Oral cryotherapy is an effective and well-tolerated therapy to alleviate mucositis and consequently reduce the number of days with i.v. opioids among patients treated with myeloablative therapy before BMT.
Anncarin Svanberg; Gunnar Birgegård; Kerstin Ohrn
Related Documents :
11374599 - Preoperative anxiolysis and postoperative recovery in women undergoing abdominal hyster...
8048199 - Postoperative morbidity is similar in patients anesthetized with epidural and general a...
9058129 - The feasibility of epidural anesthesia without endotracheal intubation for abdominal su...
17848759 - High thoracic epidural anaesthesia and post operative analgesia for fast tracking patie...
17156039 - Predictive value of intrathecal narcotic trials for long-term therapy with implantable ...
16651569 - Efficacy of periarticular multimodal drug injection in total knee arthroplasty. a rando...
2885189 - Post-operative morbidity associated with the use of atracurium and vecuronium in day-ca...
24432119 - Radiographic parameters improve lower extremity prosthetic alignment.
7981169 - Achalasia in childhood and adolescence.
Publication Detail:
Type:  Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2007-03-29
Journal Detail:
Title:  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer     Volume:  15     ISSN:  0941-4355     ISO Abbreviation:  Support Care Cancer     Publication Date:  2007 Oct 
Date Detail:
Created Date:  2007-09-19     Completed Date:  2008-01-24     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9302957     Medline TA:  Support Care Cancer     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  1155-61     Citation Subset:  IM    
Department of Haematology, Akademiska Hospital, Avdelning 50C. 75185, Uppsala, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analgesics, Opioid / therapeutic use*
Bone Marrow Transplantation
Cryotherapy* / methods
Middle Aged
Myeloablative Agonists / therapeutic use*
Stomatitis / prevention & control*
Reg. No./Substance:
0/Analgesics, Opioid; 0/Myeloablative Agonists

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Intraclass correlation metrics for the accuracy of algorithmic definitions in a computerized decisio...
Next Document:  Effectiveness of bisphosphonates on bone pain and quality of life in breast cancer patients with met...